WHO ICTRP trial
A double-blind study in subjects with active psoriatic arthritis to evaluate…
EUCTR2019-003405-94-HU · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2019-003405-94-HU |
|---|---|
| Public title | A double-blind study in subjects with active psoriatic arthritis to evaluate efficacy, tolerability, safety of two different dose levels of ABY-035 compared to placebo. |
| Scientific title | A multicenter, randomized, double-blind, placebo-controlled, dose-finding clinical trial inpatients with active psoriatic arthritis to investigate efficacy, tolerability, safety, pharmacokinetics and immunogenicity of ABY-035 |
| Primary sponsor | Affibody AB |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Czechia;Hungary;Spain;Poland;Belgium;Austria;Germany;Sweden |
| Conditions | Active Psoriatic Arthritis MedDRA version: 21.0 Level: LLT Classification code 10037160 Term: Psoriatic arthritis System Organ Class: 100000004859 ;Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05] |
| Interventions | Product Name: ABY-035 Pharmaceutical Form: Solution for injection CAS Number: 2226130-02-3 Current Sponsor code: ABY-035 Other descriptive name: Recombinant protein comprising two IL-17A binding domains and an albumin binding domain… |
| Registration date | Nov 21, 2019 |
| Target size | 129 |
| Secondary IDs | ABY-035-202 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: